We’ve all felt winded when taking the stairs or dealt with a cough from time to time. But if these issues linger, they could be early signs of chronic obstructive pulmonary disease (COPD). If you have ...

For patients with chronic obstructive pulmonary disease, healing from home may be as good as receiving treatment in hospital, according to new research. “We know that pulmonary rehab is a highly ...

COPD is a group of progressive lung diseases that includes emphysema and chronic bronchitis. Despite affecting an estimated 32 million people in the United States, as many as half are unaware they ...

The FDA approved Ohtuvayre (ensifentrine) as a maintenance therapy for COPD (chronic obstructive pulmonary disease). The medication works as both a bronchodilator and an anti-inflammatory to ease ...

The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a ...

New trial analysis shows COPD treatment withdrawal, including LAMA and ICS discontinuation, can trigger early exacerbation ...

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is a prescription drug used to treat COPD. With COPD, you have lung damage that worsens over time ...

FLORENCE, Italy — Exacerbations remain one of the major unresolved challenges in the management of chronic obstructive pulmonary disease (COPD), despite the introduction of new therapies. However, ...

May 23, 2025 -- The FDA has approved the asthma drug Nucala for adults with chronic obstructive pulmonary disease (COPD). It is the second biologic therapy approved for the condition, following the ...

In May 2025, the FDA approved mepolizumab (Nucala) as a treatment for chronic obstructive pulmonary disease (COPD). Before any drug gets near a pharmacy shelf, it starts with years of basic science ...